Moreover, the cell–cell interactions suggest that tumor cells communicate extensively with immune cells and that inflammatory and adaptive immune responses are mediated by various immunomodulatory molecules (e.g., TIGIT, CD96, CD47, CSF1R, and XCL1/2-XCR1) that have rarely been studied before in NPC. This evidence concerns the gene CD96 and nasopharyngeal carcinoma.